The role of gut hormones in the pathogenesis and management of obesity
Tài liệu tham khảo
WHO, 2018
Dokken, 2007, The physiology of body weight regulation: are we too efficient for our own good?, Diabetes Spectr, 20, 166, 10.2337/diaspect.20.3.166
Latorre, 2016, Enteroendocrine cells: a review of their role in brain–gut communication, Neurogastroenterol Motil, 28, 620, 10.1111/nmo.12754
Manning, 2014, Enteroendocrine MC4R and energy balance: linking the long and the short of it, Cell Metab, 20, 929, 10.1016/j.cmet.2014.11.014
Panaro, 2014, The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo, Cell Metab, 20, 1018, 10.1016/j.cmet.2014.10.004
Liu, 2017, Enhanced AMPA receptor trafficking mediates the anorexigenic effect of endogenous glucagon-like peptide-1 in the paraventricular hypothalamus, Neuron, 96, 897, 10.1016/j.neuron.2017.09.042
Neary, 2005, Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively, Endocrinology, 146, 5120, 10.1210/en.2005-0237
Grunddal, 2016, Neurotensin is coexpressed, coreleased, and acts together with GLP-1 and PYY in enteroendocrine control of metabolism, Endocrinology, 157, 176, 10.1210/en.2015-1600
Ronveaux, 2015, Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling, J Nutr, 145, 672, 10.3945/jn.114.206029
Kentish, 2013, Gastric vagal afferent modulation by leptin is influenced by food intake status, J Physiol, 591, 1921, 10.1113/jphysiol.2012.247577
de Lartigue, 2018, Mechanisms of vagal plasticity influencing feeding behavior, Brain Res, 1693, 146, 10.1016/j.brainres.2018.03.030
De Silva, 2011, The gut hormones PYY3-36 and GLP-17-36 amide reduce food intake and modulate brain activity in appetite centers in humans, Cell Metab, 14, 700, 10.1016/j.cmet.2011.09.010
Dockray, 2012, Cholecystokinin, Curr Opin Endocrinol Diabetes Obes, 19, 8, 10.1097/MED.0b013e32834eb77d
Plovier, 2017, Enteroendocrine cells: metabolic relays between microbes and their host, Endocr Dev, 10.1159/000475736
Rosenbaum, 2015, The gut microbiota in human energy homeostasis and obesity, Trends Endocrinol Metab, 26, 493, 10.1016/j.tem.2015.07.002
Brighton, 2015, Bile acids trigger GLP-1 release predominantly by accessing basolaterally located G protein-coupled bile acid receptors, Endocrinology, 156, 3961, 10.1210/en.2015-1321
Cummings, 2015, Taste and the regulation of food intake: it’s not just about flavor, Am J Clin Nutr, 102, 717, 10.3945/ajcn.115.120667
Zolotukhin, 2013, Metabolic hormones in saliva: origins and functions, Oral Dis, 19, 219, 10.1111/odi.12015
Loch, 2015, Endocrine modulation of olfactory responsiveness: effects of the orexigenic hormone ghrelin, Chem Senses, 40, 469, 10.1093/chemse/bjv028
Batterham, 2007, PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans, Nature, 450, 106, 10.1038/nature06212
Russo, 2018, Ghrelin-containing neurons in the olfactory bulb send collateralized projections into medial amygdaloid and arcuate hypothalamic nuclei: neuroanatomical study, Exp Brain Res, 236, 2223, 10.1007/s00221-018-5298-z
Ghanemi, 2018, Broken energy homeostasis and obesity pathogenesis: the surrounding concepts, J Clin Med, 7, 10.3390/jcm7110453
Steinert, 2016, Ghrelin, CCK, GLP-1, and PYY (3–36): secretory controls and physiological roles in eating and glycemia in health, obesity, and after RYGB, Physiol Rev, 97, 411, 10.1152/physrev.00031.2014
Onnerfalt, 2018, Obese children aged 4-6 displayed decreased fasting and postprandial ghrelin levels in response to a test meal, Acta Paediatr, 107, 523, 10.1111/apa.14165
Broussard, 2016, Elevated ghrelin predicts food intake during experimental sleep restriction, Obesity (Silver Spring), 24, 132, 10.1002/oby.21321
Wu, 2017, Suppression of GHS-R in AgRP neurons mitigates diet-induced obesity by activating thermogenesis, Int J Mol Sci, 18, 832, 10.3390/ijms18040832
Auguet, 2018, Low circulating levels of neurotensin in women with nonalcoholic fatty liver disease associated with severe obesity, Obesity (Silver Spring), 26, 274, 10.1002/oby.22058
Di Guglielmo, 2018, Pilot study measuring the novel satiety hormone, pro-uroguanylin, in adolescents with and without obesity, J Pediatr Gastroenterol Nutr, 66, 489, 10.1097/MPG.0000000000001796
Moghadam, 2017, Alterations in circadian and meal-induced gut peptide levels in lean and obese rats, Exp Biol Med (Maywood), 242, 1786, 10.1177/1535370217732041
Wölnerhanssen, 2017, Deregulation of transcription factors controlling intestinal epithelial cell differentiation; a predisposing factor for reduced enteroendocrine cell number in morbidly obese individuals, Sci Rep, 7, 10.1038/s41598-017-08487-9
Rosenbaum, 2014, 20 years of leptin: role of leptin in energy homeostasis in humans, J Endocrinol, 223, T83, 10.1530/JOE-14-0358
Field, 2010, PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans, Diabetes, 59, 1635, 10.2337/db09-1859
Sumithran, 2011, Long-term persistence of hormonal adaptations to weight loss, N Engl J Med, 365, 1597, 10.1056/NEJMoa1105816
Zhao, 2017, The role of gut hormones in diet-induced weight change: a systematic review, Horm Metab Res, 49, 816, 10.1055/s-0043-115646
Cummings, 2002, Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery, N Engl J Med, 346, 1623, 10.1056/NEJMoa012908
Crujeiras, 2010, Weight regain after a diet-induced loss is predicted by higher baseline leptin and lower ghrelin plasma levels, J Clin Endocrinol Metab, 95, 5037, 10.1210/jc.2009-2566
Iepsen, 2016, Successful weight loss maintenance includes long-term increased meal responses of GLP-1 and PYY3–36, Eur J Endocrinol, 174, 775, 10.1530/EJE-15-1116
King, 2011, Differential acylated ghrelin, peptide YY3–36, appetite, and food intake responses to equivalent energy deficits created by exercise and food restriction, J Clin Endocrinol Metab, 96, 1114, 10.1210/jc.2010-2735
Stubbs, 2018, A ketone ester drink lowers human ghrelin and appetite, Obesity (Silver Spring), 26, 269, 10.1002/oby.22051
Brennan, 2012, Effects of fat, protein, and carbohydrate and protein load on appetite, plasma cholecystokinin, peptide YY, and ghrelin, and energy intake in lean and obese men, Am J Physiol Gastrointest Liver Physiol, 303, G129, 10.1152/ajpgi.00478.2011
Sjostrom, 2013, Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery, J Intern Med, 273, 219, 10.1111/joim.12012
Behary, 2015, Food preferences and underlying mechanisms after bariatric surgery, Proc Nutr Soc, 74, 419, 10.1017/S0029665115002074
Goldstone, 2016, Link between increased satiety gut hormones and reduced food reward after gastric bypass surgery for obesity, J Clin Endocrinol Metab, 101, 599, 10.1210/jc.2015-2665
Makaronidis, 2016, Reported appetite, taste and smell changes following Roux-en-Y gastric bypass and sleeve gastrectomy: effect of gender, type 2 diabetes and relationship to post-operative weight loss, Appetite, 107, 93, 10.1016/j.appet.2016.07.029
Makaronidis, 2016, Potential mechanisms mediating sustained weight loss following roux-en-Y Gastric bypass and sleeve gastrectomy, Endocrinol Metab Clin North Am, 45, 539, 10.1016/j.ecl.2016.04.006
Adams, 2017, Weight and metabolic outcomes 12 years after gastric bypass, N Engl J Med, 377, 1143, 10.1056/NEJMoa1700459
Yousseif, 2014, Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans, Obes Surg, 24, 241, 10.1007/s11695-013-1066-0
Peterli, 2012, Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial, Obes Surg, 22, 740, 10.1007/s11695-012-0622-3
le Roux, 2007, Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass, Annals of surgery, 246, 780, 10.1097/SLA.0b013e3180caa3e3
Dirksen, 2013, Gut hormones, early dumping and resting energy expenditure in patients with good and poor weight loss response after Roux-en-Y gastric bypass, Int J Obes, 37, 1452, 10.1038/ijo.2013.15
Aminian, 2015, How safe is metabolic/diabetes surgery?, Diabetes Obes Metab, 17, 198, 10.1111/dom.12405
NovoNordisk, 2019
Sanofi, 2019
Jall, 2017, Monomeric GLP-1/GIP/glucagon triagonism corrects obesity, hepatosteatosis, and dyslipidemia in female mice, Mol Metab, 6, 440, 10.1016/j.molmet.2017.02.002
De Silva, 2011, The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans, Cell Metab, 14, 700, 10.1016/j.cmet.2011.09.010
Nauck, 2018, Incretin hormones: their role in health and disease, Diabetes Obes Metab, 20, 5, 10.1111/dom.13129
Valentino, 2011, A uroguanylin-GUCY2C endocrine axis regulates feeding in mice, J Clin Invest, 121, 3578, 10.1172/JCI57925
Lilly, 2019
Bose, 2010, Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding, Obesity, 18, 1085, 10.1038/oby.2009.473
Hornigold, 2018, A GLP-1:CCK fusion peptide harnesses the synergistic effects on metabolism of CCK-1 and GLP-1 receptor agonism in mice, Appetite, 127, 334, 10.1016/j.appet.2018.05.131
Norregaard, 2018, A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents, Diabetes Obes Metab, 20, 60, 10.1111/dom.13034
von Loeffelholz, 2018, The anorexigenic peptide neurotensin relates to insulin sensitivity in obese patients after BPD or RYGB metabolic surgery, Int J Obes (Lond), 42, 2057, 10.1038/s41366-018-0084-3
